Gregory D. Kirk
Impact in
- Hepatology top 0.1%
- Hepatitis C virus research
- Virology top 0.5%
- HIV Research and Treatment
Papers in
- Epidemiology 123
- HIV, Drug Use, Sexual Risk 51
- Hepatitis B Virus Studies 39
- Pneumocystis jirovecii pneumonia detection and treatment 23
- Liver Disease Diagnosis and Treatment 22
- Hepatology 48
- Hepatitis C virus research 43
- Co-authors
- Shruti H. Mehta (137 shared papers)David L. Thomas (38 shared papers)James J. Goedert (35 shared papers)Jacquie Astemborski (57 shared papers)David Vlahov (18 shared papers)Chloe L. Thio (14 shared papers)Sharyne Donfield (16 shared papers)Stephen R. Cole (7 shared papers)
- Journals
- The Journal of Infectious Diseases (25 papers)Drug and Alcohol Dependence (18 papers)PLoS ONE (15 papers)Clinical Infectious Diseases (14 papers)AIDS (14 papers)
- Partner nations
- United StatesFranceGambia
In The Last Decade
Gregory D. Kirk
260 papers receiving 10.8k citations
Gregory D. Kirk's Hit Papers
Peers
Comparison fields: 5 of 162
- Hepatology 3.0k
- Virology 1.1k
- Epidemiology 4.3k
- Emergency Medicine 905
- Infectious Diseases 1.7k
Countries citing papers authored by Gregory D. Kirk
This map shows the geographic impact of Gregory D. Kirk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory D. Kirk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory D. Kirk more than expected).
Fields of papers citing papers by Gregory D. Kirk
This network shows the impact of papers produced by Gregory D. Kirk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory D. Kirk. The network helps show where Gregory D. Kirk may publish in the future.
Co-authors
The 25 scholars most cited alongside Gregory D. Kirk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 275 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Genetic variation in IL28B and spontaneous clearance of hepatitis C virus Hit paper breakdown → | 2009 | 1625 |
| 2 | 2009 | 392 | |
| 3 | 2007 | 291 | |
| 4 | 2007 | 283 | |
| 5 | 2008 | 228 | |
| 6 | 2004 | 165 | |
| 7 | 2010 | 142 | |
| 8 | 2000 | 139 | |
| 9 | 2006 | 137 | |
| 10 | 2013 | 136 | |
| 11 | 2005 | 128 | |
| 12 | 2012 | 126 | |
| 13 | 2013 | 125 | |
| 14 | 2000 | 124 | |
| 15 | 2009 | 121 | |
| 16 | 2018 | 118 | |
| 17 | 2014 | 113 | |
| 18 | 2007 | 109 | |
| 19 | 2011 | 105 | |
| 20 | 2006 | 101 |
About Gregory D. Kirk
Gregory D. Kirk is a scholar working on Epidemiology, Hepatology, Infectious Diseases, Virology and Emergency Medicine, having authored 275 papers that have together received 11.0k indexed citations. Recurring topics across this work include HIV, Drug Use, Sexual Risk (51 papers), Hepatitis C virus research (43 papers), HIV Research and Treatment (40 papers), Hepatitis B Virus Studies (39 papers), HIV/AIDS Research and Interventions (24 papers), Pneumocystis jirovecii pneumonia detection and treatment (23 papers), Liver Disease Diagnosis and Treatment (22 papers) and HIV-related health complications and treatments (18 papers). The work is most often cited by research in Hepatology (3.0k citations), Virology (1.1k citations), Epidemiology (4.3k citations), Emergency Medicine (905 citations) and Infectious Diseases (1.7k citations). Gregory D. Kirk has collaborated with scholars based in United States, France and Gambia. Frequent co-authors include Shruti H. Mehta, David L. Thomas, James J. Goedert, Jacquie Astemborski, David Vlahov, Chloe L. Thio, Sharyne Donfield, Stephen R. Cole, Mary Carrington and Meredith S. Shiels. Their work appears in journals such as The Journal of Infectious Diseases, Drug and Alcohol Dependence, PLoS ONE, Clinical Infectious Diseases and AIDS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.